Watchlist Price Alert

Rhythm Pharmaceuticals In... (RYTM)

NASDAQ: RYTM · Real-Time Price · USD

61.42

-0.87 (-1.40%)

At close: Jun 26, 2025, 3:59 PM

Rhythm Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	89.14M	60.08M	127.68M	59.25M	100.85M	62.29M	49.54M	34.24M	6.54M
Short-Term Investments	231.43M	215.76M	205.61M	235.61M	71.94M	230.16M	202.52M	113.85M	4M
Long-Term Investments	n/a	n/a	328K	328K	403K	403K	401K	225K	225K
Other Long-Term Assets	7.79M	15.33M	16.98M	12.14M	n/a	n/a	n/a	n/a	9K
Receivables	18.51M	14.87M	6.22M	1.02M	n/a	n/a	n/a	n/a	n/a
Inventory	18.74M	8.62M	2.92M	111K	n/a	n/a	n/a	n/a	n/a
Other Current Assets	8.8M	6.67M	11.81M	3.99M	8.88M	9.95M	6.63M	2.59M	216K
Total Current Assets	374.2M	308.27M	354.24M	308.39M	181.67M	302.4M	258.69M	150.67M	11.18M
Property-Plant & Equipment	4.11M	2.12M	3.38M	4.33M	5M	5.72M	1.12M	840K	930K
Goodwill & Intangibles	6.17M	7.03M	7.88M	4.66M	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	18.07M	24.48M	28.25M	21.14M	5.41M	6.12M	1.52M	1.06M	1.16M
Total Assets	392.27M	332.75M	382.48M	329.52M	187.07M	308.52M	260.21M	151.74M	12.34M
Account Payables	12.33M	4.88M	4.8M	5.74M	4.9M	10.41M	7.64M	2.43M	1.9M
Deferred Revenue	1.29M	1.29M	1.43M	7M	12.38M	13.15M	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	684K	606K	535K	472K	n/a	n/a	n/a
Other Current Liabilities	101.9M	32.82M	20.77M	21.11M	-355K	-95K	n/a	83K	76K
Total Current Liabilities	115.52M	55.2M	39.81M	43.43M	17.99M	24.42M	13.58M	6.72M	4.73M
Long-Term Debt	3.94M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	108.27M	107.29M	77.15M	n/a	n/a	n/a	372K	228K	311K
Total Long-Term Liabilities	112.21M	107.78M	78.41M	1.95M	2.55M	3.09M	372K	228K	311K
Total Liabilities	227.72M	162.99M	118.22M	45.37M	20.55M	27.5M	13.95M	6.95M	5.04M
Total Debt	3.94M	1.26M	1.94M	2.55M	3.09M	3.56M	n/a	n/a	n/a
Common Stock	61K	59K	56K	50K	44K	44K	34K	27K	10K
Retained Earnings	-1.16B	-894.74M	-710.06M	-528.94M	-459.33M	-325.33M	-184.6M	-110.25M	-76.54M
Comprehensive Income	-39K	134K	-92K	-1K	49K	n/a	-809K	-367K	-144K
Shareholders Equity	21.73M	169.76M	264.26M	284.15M	166.53M	281.02M	246.26M	144.79M	7.3M
Total Investments	231.43M	215.76M	205.61M	235.61M	71.94M	230.16M	202.52M	113.85M	4M